The impact of sequencing PD-1/PD-L1 inhibitors and stereotactic radiosurgery for patients with brain metastasis

BACKGROUND: The response of brain metastases (BM) treated with stereotactic radiosurgery (SRS) and immune checkpoint inhibitors (ICIs; programmed cell death 1 and its ligand) is of significant interest. METHODS: Patients were divided into cohorts based on ICI sequencing around SRS. The primary outco...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Neuro Oncol
Glavni autori: Kotecha, Rupesh, Kim, Joseph M, Miller, Jacob A, Juloori, Aditya, Chao, Samuel T, Murphy, Erin S, Peereboom, David M, Mohammadi, Alireza M, Barnett, Gene H, Vogelbaum, Michael A, Angelov, Lilyana, Suh, John H, Ahluwalia, Manmeet S
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2019
Teme:
Clinical Investigations
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6682202/
https://ncbi.nlm.nih.gov/pubmed/30796838
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz046
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items